140 related articles for article (PubMed ID: 36609114)
1. Successful 10-year outcomes after supracricoid partial laryngectomy for selected glottic squamous cell carcinoma classified as T3N0M0: A STROBE analysis.
Laccourreye O; Chambrin G; Garcia D; Troux C; Mirghani H; Giraud P
Eur Ann Otorhinolaryngol Head Neck Dis; 2023 Aug; 140(4):165-170. PubMed ID: 36609114
[TBL] [Abstract][Full Text] [Related]
2. Neo-adjuvant chemotherapy and supracricoid partial laryngectomy with cricohyoidopexy for advanced endolaryngeal carcinoma classified as T3-T4: 5-year oncologic results.
Laccourreye O; Brasnu D; Biacabe B; Hans S; Seckin S; Weinstein G
Head Neck; 1998 Oct; 20(7):595-9. PubMed ID: 9744458
[TBL] [Abstract][Full Text] [Related]
3. Supracricoid partial laryngectomy for primary and recurrent laryngeal cancer.
Sperry SM; Rassekh CH; Laccourreye O; Weinstein GS
JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1226-35. PubMed ID: 24092390
[TBL] [Abstract][Full Text] [Related]
4. Supracricoid partial laryngectomy cricohyoidoepiglottopexy (SCPL-CHEP) versus vertical partial laryngectomy for the treatment of glottic carcinoma.
Zhang SY; Lu ZM; Chen LS; Luo XN; Ge PJ; Song XH; Chen SH; Wu YL
Eur Arch Otorhinolaryngol; 2013 Mar; 270(3):1027-34. PubMed ID: 23241822
[TBL] [Abstract][Full Text] [Related]
5. Horizontal supraglottic partial laryngectomy for selected squamous carcinoma of the vallecula.
Laccourreye L; Garcia D; Ménard M; Brasnu D; Laccourreye O; Holsinger FC
Head Neck; 2008 Jun; 30(6):756-64. PubMed ID: 18286490
[TBL] [Abstract][Full Text] [Related]
6. Supracricoid partial laryngectomy with cricohyoidoepiglottopexy for "early" glottic carcinoma classified as T1-T2N0 invading the anterior commissure.
Laccourreye O; Muscatello L; Laccourreye L; Naudo P; Brasnu D; Weinstein G
Am J Otolaryngol; 1997; 18(6):385-90. PubMed ID: 9395014
[TBL] [Abstract][Full Text] [Related]
7. Local control after supracricoid partial laryngectomy for "advanced" endolaryngeal squamous cell carcinoma classified as T3.
Dufour X; Hans S; De Mones E; Brasnu D; Ménard M; Laccourreye O
Arch Otolaryngol Head Neck Surg; 2004 Sep; 130(9):1092-9. PubMed ID: 15381597
[TBL] [Abstract][Full Text] [Related]
8. A clinical trial of continuous cisplatin-fluorouracil induction chemotherapy and supracricoid partial laryngectomy for glottic carcinoma classified as T2.
Laccourreye O; Weinstein G; Brasnu D; Bassot V; Cauchois R; Jouffre V; Garcia D; Laccourreye H
Cancer; 1994 Nov; 74(10):2781-90. PubMed ID: 7954237
[TBL] [Abstract][Full Text] [Related]
9. [Long-term efficacy of supracricoid partial laryngectomy for 298 patients with laryngeal carcinoma].
Tao L; Zhou L; Wu HT; Gong HL; Chen XL; Li XM; Li C; Zhou J
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Feb; 53(2):97-104. PubMed ID: 29429178
[No Abstract] [Full Text] [Related]
10. Supracricoid partial laryngectomy with cricothyroidopexy: a treatment for anterior vocal commissure laryngeal squamous carcinoma.
Wen WP; Su ZZ; Zhu XL; Jiang AY; Chai LP; Wang ZF; Wen YH; Lei WB
Head Neck; 2013 Mar; 35(3):311-5. PubMed ID: 22367764
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin-fluorouracil exclusive chemotherapy for T1-T3N0 glottic squamous cell carcinoma complete clinical responders: five-year results.
Laccourreye O; Brasnu D; Bassot V; Ménard M; Khayat D; Laccourreye H
J Clin Oncol; 1996 Aug; 14(8):2331-6. PubMed ID: 8708725
[TBL] [Abstract][Full Text] [Related]
12. Primary Total Laryngectomy for Endolaryngeal cT3-4M0 Squamous Cell Carcinoma: A STROBE Analysis.
Laccourreye O; Garcia D; Haroun F; Nguyen DH; Giraud P; Mirghani H
Laryngoscope; 2024 May; 134(5):2288-2294. PubMed ID: 37921374
[TBL] [Abstract][Full Text] [Related]
13. Supracricoid partial laryngectomy with crico-hyoido-epiglottopexy for glottic carcinoma with anterior commissure involvement.
Atallah I; Berta E; Coffre A; Villa J; Reyt E; Righini CA
Acta Otorhinolaryngol Ital; 2017 Jun; 37(3):188-194. PubMed ID: 28516961
[TBL] [Abstract][Full Text] [Related]
14. Management of T3N0M0 glottic carcinoma: therapeutic outcomes.
Sessions DG; Lenox J; Spector GJ; Newland D; Simpson J; Haughey BH; Chao KS
Laryngoscope; 2002 Jul; 112(7 Pt 1):1281-8. PubMed ID: 12169914
[TBL] [Abstract][Full Text] [Related]
15. Vertical partial laryngectomy versus supracricoid partial laryngectomy for selected carcinomas of the true vocal cord classified as T2N0.
Laccourreye O; Laccourreye L; Garcia D; Gutierrez-Fonseca R; Brasnu D; Weinstein G
Ann Otol Rhinol Laryngol; 2000 Oct; 109(10 Pt 1):965-71. PubMed ID: 11051438
[TBL] [Abstract][Full Text] [Related]
16. Supracricoid partial laryngectomy with cricohyoidopexy and cricohyoidoepiglottopexy: functional and oncological results.
Karasalihoglu AR; Yagiz R; Tas A; Uzun C; Adali MK; Koten M
J Laryngol Otol; 2004 Sep; 118(9):671-5. PubMed ID: 15509363
[TBL] [Abstract][Full Text] [Related]
17. Induction chemotherapy followed by supracricoid partial laryngectomy (SCPL) with cricohyoidoepiglottopexy (CHEP) in T3NO arytenoid fixation-related glottic cancer.
Luna-Oritz K; Villavicencio-Valencia V; Rodriguez-Falconi A; Alvarez-Avitia M; Granados-Garcia M; Cano-Valdez AM; Peteuil N
B-ENT; 2016; 12(4):271-277. PubMed ID: 29709130
[TBL] [Abstract][Full Text] [Related]
18. [Supracricoid partial laryngectomy as salvage for recurrent carcinoma of the larynx initially treated by vertical partial hemilaryngectomy. Case report].
Luna-Ortiz K; Nuñez-Valencia ER; Carmona-Luna T
Cir Cir; 2008; 76(4):333-7. PubMed ID: 18778545
[TBL] [Abstract][Full Text] [Related]
19. One hundred supracricoid laryngectomies with cricohyoidoepiglottopexy: do we achieve better local control?
Nakayama M; Miyamoto S; Seino Y; Okamoto T; Kano K; Hasebe M; Okamoto M
Jpn J Clin Oncol; 2015 Aug; 45(8):732-7. PubMed ID: 25981622
[TBL] [Abstract][Full Text] [Related]
20. Supracricoid partial laryngectomy in the management of t3 laryngeal cancer.
Mercante G; Grammatica A; Battaglia P; Cristalli G; Pellini R; Spriano G
Otolaryngol Head Neck Surg; 2013 Nov; 149(5):714-20. PubMed ID: 23921496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
